

I. Patient Forum "By the patient for the patient" is the motto behind this Forum. Established under the auspices of Forum for The Study of The Liver, this Forum is one of it's kind and with an unique composition consisting of hepatitis B and C patients and Hepatologists and headed by a Director of the Forum. Agenda of the Forum include facilitating and supporting access to treatment, speaking on a patient's behalf in order to further their treatment progress or to protect their rights and help them learn how to obtain information and services. Members of the Forum are entitled to discounted services offered by the Forum for the Study of The Liver at a priority basis. II. Liver Care & Research Centre Liver Care & Research Centre is the flagship project of Forum for The Study of The Liver founded with the motto "Liver Care – We Deliver". It has been established at a prime location in Dhanmondi area of Dhaka city partnering with Farabi General Hospital. The Centre is a fully equipped tertiary level Hepatology service centre having 30 inpatient beds including general wards and cabins. There is a 4 bed HDU to cater liver failure patients. The Centre is furnished with an endoscopy suite, pathology laboratory and ultrasonography services. OPD consultations are provided to liver disease patients every Sunday, Tuesday and Thursday from 3 pm to 5 pm and on Fridays from 10 am to 12 pm. Patients attending Liver Care & Research Centre receive discounted services. III. Liver Cancer Centre Liver Cancer Centre is the most advanced centre in the country offering full spectrum of management of hepatocellular carcinoma including chemotherapy, local ablations, namely percutaneous ethanol injection (PEI) and radio frequency ablation (RFA) and transarterial chemoembolization (TACE) – the most advanced modality for liver cancer management. Liver Cancer Centre is the only centre in the country at the moment where TACE is being offered. Management of HCC at Liver Care Centre is offered by a group of Hepato-Oncologists trained in India and Japan. The centre is soon going to introduce dendritic cell based immuno-therapy for the first time in the country. IV. Vaccination Vaccination against hepatitis B is provided at a subsidized rate to anyone interested every Sunday, Tuesday and Thursday from 3 pm to 5 pm and on Fridays from 10 am to 12 pm. This is in line with our commitment to eradicate hepatitis B by 2030. V. Access to Treatment Patient suffering from hepatitis B and C related diseases attending Liver Care & Research Centre receives special discount on antivirals, as part of our pledge to ensure access of treatment to the under privileged. VI. Promotion of Diagnosis Diagnosing new cases of hepatitis B and C remains the key to eradication of hepatitis B and C viruses by 2030. In order to facilitate these goal Forum for The Study of The Liver conducts screening programmes in partnership with voluntary organizations. The Forum also runs an outreach centre in Mymensingh to achieve this goal. VII. Forum for The Study of The Liver Outreach Centre Trishal, Mymensingh VIII. Publication Forum for The Study of The Liver is a co-sponsor of Euroasian Journal of Hepato-gastroenterology with Euroasian Gastroenterological Association. The journal is approved by the Bangladesh Medical and Dental Council and has bibliographic listings with IndexCopernicus, Google Scholar, ProQuest, Open J Get, HINARY, EBSCO, Genamics JournalSeek, Ulrich, SIS, OAJI and CiteFactor. Indexing with PubMed is now pending approval of the PubMed authority. website: www.ejohg.org IX. Meetings Regional Hepatitis Summit 2016 May 07, 2016 Victoria Convention Centre Road No. 14 (New), Dhanmondi Dhaka-1209, Bangladesh. Organized by Forum for The Study of The Liver in association with Communicable Disease Control (CDC) Directorate of General Services Government of Bangladesh.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close